A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: Comparison of early and late treatment and of dexamethasone and inhaled budesonide

Pediatrics

Volumn 107, Issue 2, 2001, Pages 232-240

  Halliday, Henry L ^a   Patterson, Chris C ^b   Halahakoon, Chrishanti W N L ^a  

^a ROYAL MATERNITY HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Glucocorticoids; Inhaled budesonide; Neonate; Preterm; Randomized clinical trial; Spacing chamber; Systemic dexamethasone

Indexed keywords

BUDESONIDE; DEXAMETHASONE; OXYGEN;

ARTICLE; ARTIFICIAL VENTILATION; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEATH; GASTROINTESTINAL DISEASE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; METERED DOSE INHALER; MULTICENTER STUDY; NEWBORN; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADMINISTRATION, INHALATION; BRONCHOPULMONARY DYSPLASIA; BUDESONIDE; CAUSE OF DEATH; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FACTOR ANALYSIS, STATISTICAL; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERGLYCEMIA; HYPERTENSION; INFANT, NEWBORN; INFANT, PREMATURE; LOGISTIC MODELS; MALE; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0035140563     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.107.2.232     Document Type: Article

References (33)

1. Pulmonary surfactant therapy
2. Current perspectives on the drug treatment of neonatal respiratory distress syndrome
3. Reduction in the risk of bronchopulmonary dysplasia from 1980-1990: Results of a multivariate logistic regression analysis
4. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease?
5. Health and developmental outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia
6. A risk-benefit assessment of drugs used for neonatal chronic lung disease
7. Dexamethasone for neonatal chronic lung disease
8. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia
9. Too many unvalidated new therapies to prevent chronic lung disease in preterm infants
10. Dexamethasone therapy in neonatal chronic lung disease: An international placebo-controlled trial
11. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review)
12. Clinical trials of postnatal corticosteroids: Inhaled and systemic
13. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome
14. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome
15. Early (<96 hours) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review)
16. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review)
17. The influence of betamethasone and dexamethasone on motor development in young rats
18. Early postnatal (<12 hrs) dexamethasone therapy for prevention of BPD in preterm infants with RDS - A two-year follow-up study
19. Randomized placebocontrolled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age
20. Aerosol therapy in the newborn
21. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia
22. Delivery of therapeutic aerosols to intubated babies
23. The CRIB (Clinical Risk Index for Babies) score: A tool for assessing initial neonatal risk and comparing performance of neonatal intensive care hospitals
24. Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial)
25. Inflammatory mediators and bronchopulmonary dysplasia
26. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops
27. Ventilator-induced lung injury
28. A review of postnatal corticosteroids for treatment and prevention of chronic lung disease in the preterm infant
29. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease
30. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of infants at risk for chronic lung disease
31. Treatment of bronchopulmonary dysplasia
32. Early postnatal dexamethasone therapy for the prevention of chronic lung disease
33. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birthweight preterm neonates (Cochrane Review)